Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients with Assist Device

Phase 4

Recruiting

Conditions: Bleeding
Clot Blood

Interventions: Drug: Warfarin
Drug: Aspirin

First Posted Date: 2024-10-23

Last Posted Date: 2024-10-23

Lead Sponsor: Columbia University

Target Recruit Count: 128

Registration Number: NCT06655376

Locations: 🇺🇸
Columbia Irving Medical Center, New York, New York, United States

Free Time For Wellness 2+

Not Applicable

Recruiting

Conditions: Physical Inactivity

First Posted Date: 2024-10-23

Last Posted Date: 2024-12-17

Lead Sponsor: Columbia University

Target Recruit Count: 630

Registration Number: NCT06654843

Locations: 🇺🇸
Thomas Jefferson Recreation Center, New York, New York, United States
🇺🇸
Highbridge Park, New York, New York, United States
🇺🇸
Jackie Robinson Recreation Center, New York, New York, United States

Efficacy of Nanodropper-mediated Topical Anesthetic

Phase 4

Recruiting

Conditions: Corneal Diseases
Effectiveness of Microdrops

First Posted Date: 2024-10-15

Last Posted Date: 2025-01-13

Lead Sponsor: Columbia University

Target Recruit Count: 41

Registration Number: NCT06636708

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Synbiotic Therapy for NP-PASC

Not Applicable

Recruiting

Conditions: Post-Acute COVID-19 Syndrome
Long COVID-19

First Posted Date: 2024-10-01

Last Posted Date: 2025-01-16

Lead Sponsor: Columbia University

Target Recruit Count: 30

Registration Number: NCT06620406

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Discogen for Low Back Pain

Not Applicable

Recruiting

Conditions: Disc Herniation

First Posted Date: 2024-09-25

Last Posted Date: 2025-05-23

Lead Sponsor: Columbia University

Target Recruit Count: 5

Registration Number: NCT06611397

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Diazoxide Suppression Test P&F Study

Phase 1

Recruiting

Conditions: Insulin Resistance
Hyperinsulinemia
Obesity

Interventions: Drug: Diazoxide, 3 mg/kg per dose

First Posted Date: 2024-09-23

Last Posted Date: 2025-01-08

Lead Sponsor: Columbia University

Target Recruit Count: 10

Registration Number: NCT06606327

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Temporal Interference Stimulation for Social Cognition

Not Applicable

Recruiting

Conditions: Healthy Controls

First Posted Date: 2024-09-23

Last Posted Date: 2025-03-07

Lead Sponsor: Columbia University

Target Recruit Count: 30

Registration Number: NCT06607432

Locations: 🇺🇸
Columbia University Irving Medical Center/NewYork-Presbyterian Hospital (CUIMC/NYPH), New York, New York, United States

Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season

Not Applicable

Active, not recruiting

Conditions: Influenza
COVID-19
Vaccination Hesitancy

First Posted Date: 2024-09-19

Last Posted Date: 2025-01-16

Lead Sponsor: Columbia University

Target Recruit Count: 50000

Registration Number: NCT06603090

Locations: 🇺🇸
American Academy of Pediatrics, Itasca, Illinois, United States
🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

and more 1 locations

Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Phase 1

Not yet recruiting

Conditions: Alzheimer Disease, Early Onset

Interventions: Device: Neuronavigation-guided single-element focused ultrasound transducer
Drug: Lumason
Other: Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents
Radiation: Positron Emission Tomography (PET)
Drug: Amyvid
Drug: MK-6240
Drug: Dotarem
Diagnostic Test: Blood draw
Device: UR5e
Diagnostic Test: Urine test

First Posted Date: 2024-09-19

Last Posted Date: 2025-05-11

Lead Sponsor: Columbia University

Target Recruit Count: 6

Registration Number: NCT06600880

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Phase 2

Recruiting

Conditions: Mild Cognitive Impairment (MCI)
Cognitive Training

First Posted Date: 2024-09-19

Last Posted Date: 2025-06-27

Lead Sponsor: Columbia University

Target Recruit Count: 240

Registration Number: NCT06601933

Locations: 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
University of Washington, Seattle, Washington, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy